These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1367365)

  • 21. Berkeley dispute festers over biotech deal.
    Dalton R
    Nature; 1999 May; 399(6731):5. PubMed ID: 10331373
    [No Abstract]   [Full Text] [Related]  

  • 22. Political deadlock delays promised German research cash.
    Schiermeier Q
    Nature; 2005 Feb; 433(7025):448. PubMed ID: 15690005
    [No Abstract]   [Full Text] [Related]  

  • 23. Blurred vision.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
    [No Abstract]   [Full Text] [Related]  

  • 24. NASD rule requires disclosure.
    Bouchie A
    Nat Biotechnol; 2001 Aug; 19(8):705. PubMed ID: 11491105
    [No Abstract]   [Full Text] [Related]  

  • 25. China pushes liver proteomics.
    Jia H; Louët S
    Nat Biotechnol; 2004 Feb; 22(2):136. PubMed ID: 14755276
    [No Abstract]   [Full Text] [Related]  

  • 26. Dissent grows over Helmholtz proposals.
    Abbott A
    Nature; 2001 May; 411(6834):121. PubMed ID: 11346750
    [No Abstract]   [Full Text] [Related]  

  • 27. Biotechs opt for alternative floatation strategy.
    Ratner M
    Nat Biotechnol; 2012 Sep; 30(9):814. PubMed ID: 22965036
    [No Abstract]   [Full Text] [Related]  

  • 28. Sarbanes-Oxley rules to be relaxed?
    Lawrence S
    Nat Biotechnol; 2006 Jul; 24(7):731-2. PubMed ID: 16841042
    [No Abstract]   [Full Text] [Related]  

  • 29. US Supreme Court decision could compromise biotech patents.
    Robertson D
    Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
    [No Abstract]   [Full Text] [Related]  

  • 30. Syngenta ends plant-research deal with Berkeley.
    Dalton R
    Nature; 2003 Nov; 426(6964):216. PubMed ID: 14628007
    [No Abstract]   [Full Text] [Related]  

  • 31. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 32. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

  • 33. The changing norms of the life sciences.
    Shorett P; Rabinow P; Billings PR
    Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
    [No Abstract]   [Full Text] [Related]  

  • 34. Biotechnology transfer at the National Institutes of Health.
    Chen PS
    Qual Assur; 1993 Dec; 2(4):345-52. PubMed ID: 7952969
    [No Abstract]   [Full Text] [Related]  

  • 35. Public biotech 99: the numbers.
    Lähteenmäki R; Hodgson J
    Nat Biotechnol; 2000 May; 18(5):499-503. PubMed ID: 10802615
    [No Abstract]   [Full Text] [Related]  

  • 36. US budget emphasizes bioterrorism countermeasures.
    Fox JL
    Nat Biotechnol; 2004 Mar; 22(3):256-7. PubMed ID: 14990938
    [No Abstract]   [Full Text] [Related]  

  • 37. Nontraditional publications and their effect on patentable inventions.
    Garabedian TE
    Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
    [No Abstract]   [Full Text] [Related]  

  • 38. Job compensation in the biotechnology core laboratory.
    McMillen DA; Old WM; Bleibaum JL; Nicolet CM; Resing KR; Sarath G; Yadav SP
    Nat Biotechnol; 2000 Jun; 18(6):686-9. PubMed ID: 10835613
    [No Abstract]   [Full Text] [Related]  

  • 39. The 1992 biotechnology agenda: a message for candidates Bush and Clinton.
    Duzan SA
    Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052
    [No Abstract]   [Full Text] [Related]  

  • 40. Navigating biotechnology's new fiscal opportunities.
    Purcell DJ
    Nat Biotechnol; 1998 May; 16 Suppl():51-3. PubMed ID: 9591271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.